202
Participants
Start Date
November 30, 2014
Primary Completion Date
November 30, 2017
Study Completion Date
December 3, 2018
CoreValve Transcatheter Valve
Patients should be accepted for TAVI by a multidisciplinary team. The procedure should use the Medtronic CoreValve SystemTM and point of enrolment is the day of the procedure. The choice of prosthesis size and access route (transfemoral, subclavian or direct aortic access) is to be left to the discretion of the operating team. Equally the intraprocedural details (anaesthetic, imaging etc.) will proceed as per usual practice.
CHU Brest, Brest
CHU Clermont, Clermont-Ferrand
CHU Mondor, Créteil
Clinique Parly 2 Le Chesnay, Le Chesnay
CHU Lille, Lille
HCL CHU Louis Pradel, Lyon
CHU La Timone, Marseille
Hopital Jacques Cartier, Massy
CHU de Nantes, Nantes
CHU La Pitié Salpétrière, Paris
CHU Bordeaux, Pessac
CHU Rennes, Rennes
CHU Rangueil Toulouse, Toulouse
Clinique Pasteur, Toulouse
Tonkin Clinic, Villeurbanne
Kerckhoff Klinik, Bad Nauheim
Herz- und Diabeteszentrum NRW, Bad Oeynhausen
Sana-Herzzentrum Cottbus, Cottbus
Hamburg Eppendorf, Hamburg
Herzzentrum Leipzig GmbH Leipzig, Leipzig
Rabin Medical center, Petah Tikva
Sheba Medical Center, Tel Litwinsky
Brescia Hospital, Brescia
Policlinico San Donato, Milan
Azienda Ospedaliero Universitaria Pisana, Pisa
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY